Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China

Adds production capacity to further provide customers with highly purified reagents for quality control and testing Major investment at company’s ...

July 04, 2023 | Tuesday | News
TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody

TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the F...

June 17, 2023 | Saturday | News
Cholesgen Enters Collaboration and Licensing Agreement with AstraZeneca for Hypercholesterolemia

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 17, 2023 | Saturday | News
Soliris Approved in China for Refractory Myasthenia Gravis Treatment

Soliris (eculizumab) has been approved in China for the treatment of adult patients with refractory generalised myasthenia gravis (gMG) who are anti-acetyl...

June 15, 2023 | Thursday | News
Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial1 is being led by Lanhzou Biotechnique Development  wi...

June 13, 2023 | Tuesday | News
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe

SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and supp...

June 13, 2023 | Tuesday | News
Harbour BioMed Initiates Phase I Study of First-in-Class Antibody HBM1020

  HBM1020 is a first-in-class therapeutic monoclonal antibody against B7H7/HHLA2 entering clinical development globally. HBM1020 was generated fro...

June 05, 2023 | Monday | News
Sirnaomics Initiates Phase I Study of RNAi Therapeutic STP122G for Anticoagulant Treatment

STP122G is part of the Group's GalAhead™ Factor XI RNAi therapeutic program, which has applications across a broad range of disease indications such ...

June 02, 2023 | Friday | News
Ascentage Pharma's Olverembatinib Recommended for Second Breakthrough Therapy Designation in China for SDH-Deficient GIST

This marks the second BTD granted to olverembatinib by the CDE, with the first one granted in March 2021 for the treatment of patients with chronic-phase c...

May 31, 2023 | Wednesday | News
Takeda and HUTCHMED's Fruquintinib NDA for Metastatic Colorectal Cancer Gets Priority Review

— Prescription Drug User Fee Act (PDUFA) Target Action Date set for November 30, 2023 — — NDA includes results from the Phase III FRESCO...

May 26, 2023 | Friday | News
Catalent Strengthens Cryogenic Capabilities in Shiga, Japan, Facility for Cell and Gene Therapy

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational ...

May 25, 2023 | Thursday | News
Humanetics Biomed expands its outsourced manufacturing capabilities to new markets

Humanetics Biomed is a Contract Development Manufacturing Organisation (CDMO) that combines the best biomedical technologies from Humanetics; with the tech...

May 22, 2023 | Monday | News
Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition

The cell & gene therapy (CGT) CDMO has an established global footprint with two GMP manufacturing facilities in China and its headquarters in Vancouver...

May 20, 2023 | Saturday | News
Drug Farm Secures $27M USD Financing for Hepatitis B and Cardiovascular-Renal Drugs Clinical Trials

DF-006 is a first-in-class, orally administered ALPK1 agonist immunomodulator that potently stimulates local, innate immunity in the liver, leading to a ro...

May 19, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close